Detalhe da pesquisa
1.
Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Mol Pharmacol
; 83(1): 85-94, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23053666
2.
Sec61ß controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A.
Mol Pharmacol
; 82(3): 510-20, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22710939
3.
Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency.
BMC Cancer
; 11: 61, 2011 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21303546
4.
Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Cancer Chemother Pharmacol
; 59(3): 301-12, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16770583
5.
Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells.
Cancer Chemother Pharmacol
; 58(3): 384-95, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16404635
6.
cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance.
Cancer Chemother Pharmacol
; 55(1): 1-11, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15378272
7.
Integrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1.
Oncoscience
; 1(3): 185-195, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25594011
8.
Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.
PLoS One
; 8(6): e67496, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23805314
9.
The role of metal binding and phosphorylation domains in the regulation of cisplatin-induced trafficking of ATP7B.
Metallomics
; 5(8): 964-72, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23803742
10.
Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
Neoplasia
; 14(10): 974-85, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23097631
11.
Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin.
Cancer Chemother Pharmacol
; 68(4): 979-90, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21327682
12.
Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors.
Mol Cancer Ther
; 8(7): 1906-15, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19567823
13.
Acidic hydrolysis of N-Ethoxybenzylimidazoles (NEBIs): potential applications as pH-sensitive linkers for drug delivery.
Bioconjug Chem
; 18(2): 293-6, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17261055
14.
Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
Mol Pharmacol
; 70(4): 1390-4, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16847145
15.
Identification of transdominant-negative genetic suppressor elements derived from hMSH2 that mediate resistance to 6-thioguanine.
Mol Pharmacol
; 62(5): 1198-206, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12391284
16.
Using mRNA expression profiling to determine anticancer drug efficacy.
Cytometry
; 47(1): 66-71, 2002 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11774355